JP2023535121A5 - - Google Patents
Info
- Publication number
- JP2023535121A5 JP2023535121A5 JP2022570440A JP2022570440A JP2023535121A5 JP 2023535121 A5 JP2023535121 A5 JP 2023535121A5 JP 2022570440 A JP2022570440 A JP 2022570440A JP 2022570440 A JP2022570440 A JP 2022570440A JP 2023535121 A5 JP2023535121 A5 JP 2023535121A5
- Authority
- JP
- Japan
- Prior art keywords
- parkin
- seq
- optionally
- protein
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063027868P | 2020-05-20 | 2020-05-20 | |
| US202063027866P | 2020-05-20 | 2020-05-20 | |
| US63/027,868 | 2020-05-20 | ||
| US63/027,866 | 2020-05-20 | ||
| PCT/US2021/033491 WO2021236981A2 (en) | 2020-05-20 | 2021-05-20 | Engineered parkin and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023535121A JP2023535121A (ja) | 2023-08-16 |
| JP2023535121A5 true JP2023535121A5 (OSRAM) | 2024-05-29 |
Family
ID=78707577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022570440A Pending JP2023535121A (ja) | 2020-05-20 | 2021-05-20 | 操作されたパーキン及びその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230174994A1 (OSRAM) |
| EP (1) | EP4153614A4 (OSRAM) |
| JP (1) | JP2023535121A (OSRAM) |
| CA (1) | CA3177341A1 (OSRAM) |
| WO (1) | WO2021236981A2 (OSRAM) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109641063B (zh) | 2016-04-20 | 2022-11-15 | 能源环境和技术研究中心O.A., M.P. | 用于增强pklr的基因表达的组合物和方法 |
| SG11202002263TA (en) | 2017-10-16 | 2020-04-29 | Centro De Investigaciones Energeticas Medioambientales Y Tecnologicas | Lentiviral vectors for delivery of pklr to treat pyruvate kinase deficiency |
| JP7576754B2 (ja) | 2018-04-11 | 2024-11-01 | スペースクラフト セブン リミテッド ライアビリティ カンパニー | 幹細胞移植のための組成物および方法 |
| AU2019261646A1 (en) | 2018-04-27 | 2020-11-12 | Spacecraft Seven, Llc | Gene therapy for CNS degeneration |
| IL300263A (en) | 2020-08-07 | 2023-03-01 | Spacecraft Seven Llc | Plakophilin-2 (PKP2) gene therapy using an AAV vector |
| CN119193701B (zh) * | 2024-09-13 | 2025-07-15 | 暨南大学 | 帕金森动物模型的构建方法与特异性靶向Parkin基因的gRNA及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009026116A2 (en) * | 2007-08-16 | 2009-02-26 | Genizon Biosciences, Inc. | Genemap of the human genes associated with longevity |
| WO2011053825A2 (en) * | 2009-10-30 | 2011-05-05 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Compositions and methods for the treatment or prevention of mitochondrial diseases |
| WO2012050402A2 (ko) * | 2010-10-14 | 2012-04-19 | 주식회사 프로셀제약 | 세포투과성 parkin 재조합 단백질 및 이를 함유하는 퇴행성 뇌질환 치료용 약학적 조성물 |
| US9283287B2 (en) * | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| WO2014113729A2 (en) * | 2013-01-18 | 2014-07-24 | Foundation Mecicine, Inc. | Methods of treating cholangiocarcinoma |
| AU2019261646A1 (en) * | 2018-04-27 | 2020-11-12 | Spacecraft Seven, Llc | Gene therapy for CNS degeneration |
-
2021
- 2021-05-20 US US17/926,024 patent/US20230174994A1/en active Pending
- 2021-05-20 JP JP2022570440A patent/JP2023535121A/ja active Pending
- 2021-05-20 EP EP21807784.0A patent/EP4153614A4/en active Pending
- 2021-05-20 WO PCT/US2021/033491 patent/WO2021236981A2/en not_active Ceased
- 2021-05-20 CA CA3177341A patent/CA3177341A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020203358A1 (en) | Novel micro-dystrophins and related methods of use | |
| JP2021531752A5 (OSRAM) | ||
| JP2023518596A5 (OSRAM) | ||
| JP2022520232A5 (OSRAM) | ||
| JP2022531861A5 (OSRAM) | ||
| JP2022520232A (ja) | ダノン病の治療のための遺伝子療法ベクター | |
| US20240002462A1 (en) | Treatment of neuropathy with igf-1-encoding dna constructs and hgf-encoding dna constructs | |
| JP2006502702A5 (OSRAM) | ||
| RU2019103488A (ru) | Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12 | |
| JP2019524090A5 (OSRAM) | ||
| TW202227476A (zh) | 編碼GJB2之重組腺相關病毒(rAAV)及其用途 | |
| KR20230150836A (ko) | 파브리병 치료를 위한 조성물 및 방법 | |
| JP2020517268A5 (OSRAM) | ||
| JP2022542294A5 (OSRAM) | ||
| JP2022530068A5 (OSRAM) | ||
| KR20230029624A (ko) | 유전자 치료를 위한 글루코스-6-포스파타제(G6Pase-a)를 코딩하는 벡터 | |
| JP2024528997A (ja) | 放射線誘発性唾液機能低下を予防するためのａｑｐ１遺伝子療法 | |
| JP2022530359A5 (OSRAM) | ||
| JP2024542023A5 (OSRAM) | ||
| US20190367564A1 (en) | Compositions and methods for use of anion channel rhodopsins | |
| CN111093716B (zh) | 用于治疗神经性疼痛的方法和组合物 | |
| JP2023545384A5 (OSRAM) | ||
| CN116997657A (zh) | 编码GJB2的重组腺相关病毒(rAAV)及其用途 | |
| JP7777905B2 (ja) | ４ｒタウオパチーの治療または予防用ペプチド | |
| RU2815545C2 (ru) | Генная терапия гипофосфатемических заболеваний, связанных с фактором роста фибробластов 23 |